WS
EDIT icon

Wedbush Securities’s Editas Medicine EDIT Stock Holding History

Wedbush Securities’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,615
Closed -$231K – 1188
2021
Q3 		$231K Buy
5,615
+300
+6% +$16.4K 0.01% 994
2021
Q2 		$301K Buy
+5,315
New +$196K 0.01% 861
2021
Q1 		– Sell
-4,040
Closed -$283K – 1081
2020
Q4 		$283K Buy
+4,040
New +$166K 0.02% 675

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wedbush Securities's EDIT Position: Q4 2021 in Review

Wedbush Securities sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 5,615 shares — an estimated $231K sold.

Wedbush Securities first reported a position in EDIT in Q4 2020 and held it in 3 quarters. The position peaked at $301K in Q2 2021. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Wedbush Securities reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Wedbush Securities sold 5,615 Editas Medicine shares in Q4 2021, an estimated $231K.
  • Wedbush Securities first reported a position in Editas Medicine in Q4 2020 and held it in 3 quarters.
  • Wedbush Securities's Editas Medicine position peaked at $301K in Q2 2021.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Wedbush Securities's 13F filing for Q4 2021, filed 13 Jan 2022.